Evidence map›Paper›PMID 35995908›Full record

ArticleProbiotics and antimicrobial proteins2023

Chia (Salvia hispanica L.) Seeds Contain a Highly Stable Trypsin Inhibitor with Potential for Bacterial Management Alone or in Drug Combination Therapy with Oxacillin.

Adson Ávila de Souza, Adrianne Maia Lima, Daniele Dede Oliveira BezerraSousa, Francisca Cristiane Nogueira, José Carlos do Sacramento Neto, Lucas Pinheiro Dias, Nadine Monteiro Salgueiro Araújo, Celso Shiniti Nagano, Hélio Vitoriano Nobre Júnior, Cecília Rocha da Silva and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Adson Ávila de SouzaDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Adrianne Maia LimaDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Daniele Dede Oliveira BezerraSousaDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Francisca Cristiane NogueiraDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
José Carlos do Sacramento NetoDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Lucas Pinheiro DiasDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Nadine Monteiro Salgueiro AraújoDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil.
Celso Shiniti NaganoDepartment of Fisher Engineering, Center of Agricultural Sciences, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60455-970, Brazil.
Hélio Vitoriano Nobre JúniorDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
Cecília Rocha da SilvaDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
Lívia Gurgel do Amaral Valente SáDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
João Batista de Andrade NetoDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
Fátima Daiana Dias BarrosoDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
Maria Elisabete Amaral de MoraesDrug Research and Development Center, Federal University of Ceará, Campus do Porangabussu, Fortaleza, CE, 60430-270, Brazil.
Hermógenes David de OliveiraDepartment of Biochemistry and Molecular Biology, Science Center, Federal University of Ceará, Campus do Pici Prof. Prisco Bezerra, Fortaleza, CE, 60440-900, Brazil. hermogenes@ufc.br.
Universidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic resistance poses a serious and challenging threat to healthcare systems, making it imperative to discover novel therapeutic options. This work reports the isolation and characterization of a thermostable trypsin inhibitor from chia (Salvia hispanica L.) seeds, with antibacterial activity against Staphylococcus aureus sensitive and resistant to methicillin. The trypsin inhibitor ShTI was purified from chia seeds through crude extract heat treatment, followed by affinity and reversed-phase chromatography. Tricine-SDS-PAGE revealed a single glycoprotein band of ~ 11 kDa under nonreducing conditions, confirmed by mass spectrometry analysis (11.558 kDa). ShTI was remarkably stable under high temperatures (100 °C; 120 min) and a broad pH range (2-10; 30 min). Upon exposure to DTT (0.1 M; 120 min), ShTI antitrypsin activity was partially lost (~ 38%), indicating the participation of disulfide bridges in its structure. ShTI is a competitive inhibitor (K

Indexed as

OxacillinStaphylococcus aureusAnti-Bacterial AgentsDrug CombinationsSalvia hispanicaSeedsTrypsin InhibitorsAnti-Bacterial AgentsDrug CombinationsOxacillinTrypsin InhibitorsMRSAPlant bioactive proteinProtease inhibitorSynergism

Identifiers

PMID35995908
OpenAlexW4292641417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.